key: cord-0717884-ai51kyx1
authors: Ballin, M.; Ioannidis, J. P. A.; Bergman, J.; Kivipelto, M.; Nordström, A.; Nordström, P.
title: Time-Varying Death Risk After SARS-CoV-2-Infection in Swedish Long-Term Care Facilities
date: 2022-03-13
journal: nan
DOI: 10.1101/2022.03.10.22272097
sha: 09f31bfb002697bce6bb37065a325cd24df7c7e3
doc_id: 717884
cord_uid: ai51kyx1

Importance: The case fatality rate of SARS-CoV-2 has been high among residents of long-term care (LTC) facilities. It is important to know if the excess mortality persists beyond the acute infection. Objective: To evaluate whether SARS-CoV-2 is associated with higher mortality after the first month from documented infection. Design: We extended the follow-up period of a previous, retrospective cohort study based on the Swedish Senior Alert register. LTC residents infected with SARS-CoV-2 were matched to uninfected controls using time-dependent propensity scores on age, sex, body mass index, health status, comorbidities, and prescription medication use. In a sensitivity analysis, residents were also matched on geographical region and time of Senior Alert registration. Setting: LTC facilities in Sweden. Participants: 3731 LTC residents with SARS-CoV-2 and 3731 controls (n=3604 in each group in the sensitivity analysis). Exposure: SARS-CoV-2 infection, documented in the SmiNet register (until September 15, 2020). Main Outcome: All-cause mortality over 8 months (until October 24, 2020). Results: The median age was 87 years, and 65% were women. Excess mortality was highest 5 days after documented infection (hazard ratio 19.1; 95% confidence interval [CI], 14.6-24.8), after which excess mortality decreased rapidly. After the second month, the mortality rate became lower in infected residents than in controls. Median survival of uninfected controls was 577 days (1.6 years), which is much lower than national life expectancy in Sweden at age 87 (5.05 years in men, 6.07 years in women). During days 61-210 of follow-up, the hazard ratio for death was 0.41 (95% CI, 0.34-0.50) in the main analysis and 0.76 (95% CI, 0.62-0.93) in the sensitivity analysis. Conclusions and Relevance: No excess mortality was observed in LTC residents who survived the acute SARS-CoV-2 infection (the first month). The life expectancy of uninfected residents was much lower than that of the general population of the same age and sex. This difference should be taken into account in calculations of years of life lost among LTC residents.

4 Conclusions and Relevance: No excess mortality was observed in LTC residents who survived the acute SARS-CoV-2 infection (the first month). The life expectancy of uninfected residents was much lower than that of the general population of the same age and sex. This difference should be taken into account in calculations of years of life lost among LTC residents.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 13, 2022. ;  https://doi.org/10.1101/2022.03. 10 .22272097 doi: medRxiv preprint

During the COVID-19 pandemic, many of the COVID-19 deaths that occurred in highincome countries were seen in long-term care (LTC) facilities, 1 where case fatality rates were 10-40% or even higher. 2, 3 We have previously reported that 30-day mortality in Swedish LTC was 40% in residents infected with SARS-CoV-2 versus 6% in matched, non-infected controls. 4 A natural follow-up question to ask is whether SARS-CoV-2 also increases the risk of death beyond the acute period of 30 days , i.e. whether it has long-term effects on mortality in LTC residents who recover from infection. A major concern is that LTC residents who recover from SARS-CoV-2 infection may have residual debilitation caused by the infection.

If so, this may affect also their life expectancy beyond the acute phase of the infection.

Moreover, it would be interesting to estimate the loss of life expectancy in LTC residents infected with SARS-CoV-2. We set out to answer these questions by extending the follow-up period in our previous analysis from 30 days to 8 months.

The study offers extended follow-up on a retrospective cohort study. The basic study design of the retrospective cohort and of selection of exposed (infected) and unexposed (uninfected control) residents was described in detail previously in the publication presenting 30-days of follow-up. 4 In brief, data on Swedish LTC residents were obtained from Senior Alert, a database of health assessments performed in older adults aged ≥ 65 years. 5 All residents of LTC facilities in Sweden registered in Senior Alert were eligible to be considered. Senior Alert collects health data on various conditions in adults aged ≥ 65 years.

Senior Alert captures an estimated 73% of all Swedish LTC facility residents. We selected LTC residents who had a record in Senior Alert from 2019 or 2020; the latest record during these years was used, whenever there were multiple records. Linkage used pseudo-. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 13, 2022 We excluded SARS-CoV-2 infected residents that did not have a record in Senior Alert within a year prior to date of testing or confirmed infection (whichever came first or was available) and those where dates of testing and confirmed infection were both unavailable.

Infected residents and uninfected controls were 1:1 matched with timedependent propensity scores, so as to allow for the fact that exposure (date of documented SARS-CoV-2 infection) did not coincide with the time of cohort entry (date of Senior Alert record). With time starting at the date of the Senior Alert record, a Cox model calculated a propensity score for the propensity to contract SARS-CoV-2. Each infected resident was matched to the control with the closest propensity score among those who were still alive when the SARS-CoV-2 case occurred (counting time since the Senior Alert date). Matching was done sequentially, starting with the first case (smaller number of days since cohort entry) and proceeding with cases with increasingly larger number of days since cohort entry.

Diagnoses and medications were used as time-varying covariates in the Cox regression model.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 13, 2022. ; https://doi.org/10.1101/2022.03.10.22272097 doi: medRxiv preprint

We conducted a sensitivity analysis to examine whether the results were confounded by secular trends and geographic variations in mortality. To do this, matching included also the region (21 categories) and the date (year and month) of Senior Alert registration. Using this matching procedure, 3604 infected residents could be matched to an equal number of uninfected controls.

In both the main and sensitivity analyses for death risk, all-cause mortality was considered as the outcome of interest and the starting date for follow-up was the SARS-CoV-2 documentation date in infected residents and the corresponding date (in days since cohort entry) in controls. Follow-up time in days was calculated as censor date (24 October 2020 or death whichever came first) minus baseline date + 1 day. This was done so that the baseline date could also be included in the follow-up time and analysis (thus, a person would be able to die on the same date as they were documented to be infected).

The absolute risk of death was examined using Kaplan-Meier plots. The hazard ratio (HR) for death was plotted over time using flexible parametric models with restricted cubic splines (4 knots in default positions). HRs and 95% confidence intervals (CIs) were also estimated using Cox regression for 30-day intervals of follow-up until 210 days. To adjust for matching, we calculated 95% CIs in the Cox models and the flexible parametric models using robust standard errors.

Analyses were performed using Stata MP version 16.1 for Mac (StataCorp, College Station, TX).

The study was approved by the Swedish Ethical Review Authority, which waived the informed consent requirement (no. 2020-02552). No patients were consulted in the study.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 13, 2022 In the sensitivity analysis, for infected residents, median baseline date was 26 Apr 2020 (IQR 10 Apr to 21 May), median (maximum) follow-up was 130 (246) days and there were 1640 deaths. For controls, median baseline date was 28 Apr 2021 (IQR 9 Apr to 23 May), median (maximum) follow-up was 173 (249) days and there were 536 deaths. The median age was 87 years, 65% were women, and comorbidities were common ( Table 1) .

As previously reported, SARS-CoV-2 was associated with a sharp, early increased risk of death: 40% versus 6% within 30 days (1487/3731 versus 211/3731).

However, extending the follow-up period showed that the risk soon plateaued ( Figure 1A ).

Similar results were seen in the sensitivity analysis ( Figure 1B) . is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 13, 2022. ; https://doi.org/10.1101/2022.03.10.22272097 doi: medRxiv preprint 1 first wave probably resulted in average loss of life expectancy of less than 1.6 years on average. This figure is much lower than the life expectancy in the general Swedish population, which in 2019 was 5.05 years for men and 6.07 years for women at the age of 87 (the median age in our study). 7

Calculations of burden of disease due to COVID-19 often use age-and genderadjusted life expectancies to calculate years-of-life-lost; however, without properly accounting for LTC residence and general health. Our findings suggest that such an approach can yield massively inflated estimates. 8 Adjustment for comorbidities has been shown to decrease the number of years-of-life-lost in some studies. [9] [10] [11] However, the change is typically modest (e.g., in the range of 1 years) and much smaller than what we observed in the LTC resident population that we evaluated. It is possible that in most studies, information on comorbidities is not available in sufficient granularity and accuracy regarding severity. E.g., "kidney disease" would carry very different risk connotations depending on the stage and severity. LTC resident status is a surrogate for increased frequency and severity of many comorbidities and of overall frailty. Therefore, it should be taken into account as a first correction for any years-of-life-lost estimates for COVID-19 burden of disease calculations.

Calculations accounting for LTC status and also properly adjusting for comorbidities and their severity may also lead to much lower estimates than some other increasingly used approaches such as the Global Burden of Disease Reference Life Table 12 also known as Theoretical Minimum Risk Life Table. This life table is an "aspirational" construct: it assumes an idealized situation with very low risk of death. According to this table, life expectancy is 88.9 years at birth, 9.99 years at age 85, 5.92 years at age 90, and 5.92 years at age 95. 13 Using this popular aspirational life table would probably overestimate by 5-10-fold the years-of-life-lost for SARS-CoV-2-deceased residents in LTC facilities.

Aspirational life tables have been promoted as a way to standardize burden of disease . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 13, 2022. ; https://doi.org/10.1101/2022.03.10.22272097 doi: medRxiv preprint calculations across different countries. However, in the case of diseases like COVID-19 they could lead to grossly misleading inferences.

pandemic also agree with very limited median survival of nursing home residents (e.g., 541 days in one study). 14 However, we should acknowledge that there can be large heterogeneity.

Some LTC facilities admit mostly residents with known limited life-expectancy (mostly for palliative care), while others may be institutions that admit mostly older adults who are quite healthy or have limited health problems with substantial life-expectancy. Some caveats should be discussed. Our data pertain to fatalities during the first wave of COVID-19 and until the fall of 2020. The first wave was the most devastating in most high-income countries, with a few exceptions (e.g. Australia). 15, 16 The relatively lower proportion of fatalities in LTC residents in subsequent waves may reflect a combination of multiple factors: high levels of prior infection (seroprevalence studies have found 5-10 times higher infection rates in LTC facilities than in the general population in the first wave), [17] [18] [19] better protection of nursing homes, more extensive testing, widespread use of vaccination in 2021, 16 and the possibility that the sickest individuals were the first to succumb. 20 Moreover, the significantly lower risk of death after the first month post-infection versus the uninfected controls should not be interpreted as a sign that SARS-CoV-2 infection causally decreases the risk of death during long-term follow-up, as it probably reflects mostly a selection process (residents who died in the first month were probably more sick and debilitated before infection, while those surviving probably had better life expectancy).

Allowing for these caveats, the major strength of our study is that it uses on large databases with nationwide coverage. Even so, similar analyses should also be performed in other countries because the health status of LTC residents may be different. This will allow to obtain more solid evidence on both the years-of-life-lost from the major COVID-19 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 1 3

pandemic, as well as insights about the long-term outcomes of SARS-CoV-2-infected residents of various types of LTC facilities who survived and recovered from the acute infection.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 13, 2022. ; https://doi.org/10.1101/2022.03.10.22272097 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 13, 2022 

Mortality associated with COVID-19 in care homes: international evidence. Article in LTCcovid.org, International Long-Term Care Policy Network

Risk factors associated with all-cause 30-day mortality in nursing home residents with COVID-19

Investigation of a severe SARS-CoV-2 outbreak in a long-term care home early in the pandemic

Excess Mortality After COVID-19 in Swedish Long-Term Care Facilities

Senior alert: A quality registry to support a standardized, structured, and systematic preventive care process for older adults

The Swedish cause of death register

Over-and under-estimation of COVID-19 deaths

Different approaches to quantify years of life lost from COVID-19

Reflections on key methodological decisions in national burden of disease assessments

COVID-19-exploring the implications of longterm condition type and extent of multimorbidity on years of life lost: a modelling study

Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study

Global Burden of Disease Study 2019 Reference Life Table

Survival in a cohort of social services placements in nursing and residential homes: factors associated with life expectancy and mortality. Public Health

Second versus first wave of COVID-19 deaths: Shifts in age distribution and in nursing home fatalities

Change in age distribution of COVID-19 deaths with the introduction of COVID-19 vaccination

The demography and characteristics of SARS-CoV-2 seropositive residents

Abbreviations: BMI, Body mass index

CKD, chronic kidney disease

COPD, chronic obstructive pulmonary disease

The data are displayed as number (percent) unless stated otherwise. The data in the first two columns are the same as those presented in of our previous publication